Understanding Cell Aging and Inflammation in Diabetic Eye Disease
Inflammaging and Diabetic Retinopathy
This research explores how aging cells and inflammation in the eye contribute to diabetic retinopathy, a condition that can lead to blindness in people with diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-11176815 on NIH RePORTER |
What this research studies
Diabetic retinopathy is a serious eye condition that can lead to blindness for people with diabetes. Our team is looking into how high blood sugar causes cells in the retina to age too quickly and become inflamed, a process called 'inflammaging.' These aging cells then release harmful signals that can damage other cells in the eye and contribute to vision loss. We believe that specific changes within these cells, involving certain proteins, play a central role in this damage. By understanding these detailed processes, we hope to discover new ways to protect your vision.
Who could benefit from this research
Good fit: This foundational research is for understanding the disease process, so it does not directly involve patient participation at this stage, but future clinical applications would target adults with diabetes at risk for or experiencing diabetic retinopathy.
Not a fit: Patients who do not have diabetic retinopathy or diabetes would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow down vision loss caused by diabetic retinopathy.
How similar studies have performed: While the specific mechanisms of 'inflammaging' in diabetic retinopathy are understudied, previous research has linked cellular senescence and inflammation to various age-related and diabetic complications.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Bartoli, Manuela — Augusta University
- Study coordinator: Bartoli, Manuela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.